CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AltheaDx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AltheaDx Inc
3030 Bunker Hill Street
Suite 300
Phone: (858) 882-0123p:858 882-0123 San Diego, CA  92109-5754  United States Fax: (302) 674-5266f:302 674-5266

This company was Merged or Acquired on 4/27/2022.
AltheaDx, Inc. filed a Registration Withdrawal Request of its Form S-1 (File No. 333-201220) with the SEC on 03/9/2015. The Registrant has determined not to pursue the initial public offering to which the Registration Statement relates at this time because the terms currently obtainable in the public marketplace are not sufficiently attractive to the Registrant to warrant proceeding with the public offering.
This is a Subsidiary, click here for the Parent Company

Business Summary
AltheaDx, Inc. is a United States-based molecular diagnostics company. The Company is specialized in the field of pharmacogenetics. The Company focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. The Company’s IDgenetix pharmacogenetic testing portfolio addresses various clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201412/31/2013YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board FrancoisFerre 1/1/2015 1/1/2008
President, Chief Executive Officer Jorge A.Garces 46 1/1/2015 6/1/2013
Chief Financial Officer AndrewJackson
Senior Vice President, Regulatory Affairs and Quality Assurance JoelCenteno
Senior Vice President - Operations AndrewLukowiak

General Information
Number of Employees: 77 (As of 12/31/2014)
Outstanding Shares: 12,372,003 (As of 2/3/2015)
Stock Exchange: NASD
Federal Tax Id: 262018451
Fax Number: (302) 674-5266


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023